Combination treatment with all-trans retinoic acid prevents cisplatin-induced enrichment of CD133+ tumor-initiating cells and reveals heterogeneity of cancer stem cell compartment in lung cancer

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Combination treatment with all-trans retinoic acid prevents cisplatin-induced enrichment of CD133<sup>+</sup> tumor-initiating cells and reveals heterogeneity of cancer stem cell compartment in lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences